Cellino raises $16M scaling up personalized regenerative medicine
Longevity Technology - 02-Feb-2021Biotech startup to make stem-cell based therapies to extend and save lives
Join the club for FREE to access the whole archive and other member benefits.
Biotechnology, Healthcare, Machine Learning and Partner at Khosla Ventures
Alex is a Partner on the investment team at Khosla Ventures where he has a special focus in biotechnology, healthcare, data science, and AI/ML. Alex has an MD and PhD in biomedical informatics from Stanford, with a dissertation on machine learning methods in precision medicine under the supervision of Atul Butte. Alex has completed additional graduate work in biology and physics and a short postdoctoral fellowship in biochemistry and genetics with Ronald W. Davis at the Stanford Genome Technology Center.
As a scientist, he has published over 50 scientific publications, primarily at the intersection of computer science, biology, and healthcare. As an inventor, he has licensed IP to three separate companies. As an entrepreneur, he has worked as an early employee or co-founder at a range of startups. He currently sits on the boards of some of Khosla Ventures’ investments, including Deep Genomics and HeartVista.
Visit website: https://www.khoslaventures.com/team/alex-morgan
See also: Khosla Ventures - Venture Capital & Private Equity company
Details last updated 03-Feb-2021
Biotech startup to make stem-cell based therapies to extend and save lives